Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Vaccines

Free Subscription 16.12.2019 1 Ann Intern Med 1 BMJ 1 Clin Infect Dis 1 Infect Immun 1 J Immunol 3 J Infect Dis 1 J Virol 1 JAMA 3 Pediatr Infect Dis J 1 PLoS Med 3 PLoS One 1 Proc Natl Acad Sci U S A 15 Vaccine

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Intern Med

1. LAPRISE JF, Chesson HW, Markowitz LE, Drolet M, et al
   Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States.
   Ann Intern Med. 2019 Dec 10. pii: 2757403. doi: 10.7326/M19-1182.
   PubMed     Text format     Abstract available
   
   

   
   BMJ

2. IACOBUCCI G
   NHS staff and patients urged to get vaccinated as flu season starts early.
   BMJ. 2019;367:l6900.
   PubMed     Text format    
   
   

   
   Clin Infect Dis

3. COWLING BJ, Perera RAPM, Valkenburg SA, Leung NHL, et al
   Comparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled Trial.
   Clin Infect Dis. 2019 Dec 12. pii: 5673516. doi: 10.1093/cid/ciz1034.
   PubMed     Text format     Abstract available
   
   

   
   Infect Immun

4. MANGAS KM, Buultjens AH, Porter JL, Baines SL, et al
   Vaccine-specific immune responses against Mycobacterium ulcerans infection in a low-dose murine challenge model.
   Infect Immun. 2019 Dec 9. pii: IAI.00753-19. doi: 10.1128/IAI.00753.
   PubMed     Text format     Abstract available
   
   

   
   J Immunol

5. SAUTTO GA, Kirchenbaum GA, Abreu RB, Ecker JW, et al
   A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin.
   J Immunol. 2019 Dec 6. pii: jimmunol.1900379. doi: 10.4049/jimmunol.1900379.
   PubMed     Text format     Abstract available
   
   

   
   J Infect Dis

6. BENNETT A, Pollock L, Jere KC, Pitzer VE, et al
   Duration and Density of Fecal Rotavirus Shedding in Vaccinated Malawian Children With Rotavirus Gastroenteritis.
   J Infect Dis. 2019 Dec 13. pii: 5676855. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
7. HENSS L, Yue C, von Rhein C, Tschismarov R, et al
   Analysis of humoral immune responses in chikungunya virus (CHIKV) infected patients and individuals vaccinated with a candidate CHIKV vaccine.
   J Infect Dis. 2019 Dec 12. pii: 5673548. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
8. WAGSTAFFE HR, Clutterbuck EA, Bockstal V, Stoop JN, et al
   Antibody-Dependent Natural Killer Cell Activation after Ebola Vaccination.
   J Infect Dis. 2019 Dec 10. pii: 5672569. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   J Virol

9. VERMA A, Schmidt BA, Elizaldi SR, Nguyen NK, et al
   Impact of Th1 CD4 TFH skewing on Antibody Responses to an HIV-1 Vaccine in Rhesus Macaques.
   J Virol. 2019 Dec 11. pii: JVI.01737-19. doi: 10.1128/JVI.01737.
   PubMed     Text format     Abstract available
   
   

   
   JAMA

10. KUEHN B
    Kindergarten Vaccine Coverage Needs a Boost.
    JAMA. 2019;322:2162.
    PubMed     Text format    
    
    

    
    Pediatr Infect Dis J

11. KAWABATA T, Tenokuchi Y, Yamakuchi H, Sameshima H, et al
    Concurrent Bacteremia Due to Non-vaccine Serotype 24F Pneumococcus in Twins: A Rapid Increase in Serotype 24F-invasive Pneumococcal Disease and its High Invasive Potential.
    Pediatr Infect Dis J. 2020;39:85-87.
    PubMed     Text format     Abstract available
    
    
12. DUBUS M, Ladhani S, Vasu V
    Prophylactic Paracetamol After Meningococcal B Vaccination Reduces Postvaccination Fever and Septic Screens in Hospitalized Preterm Infants.
    Pediatr Infect Dis J. 2020;39:78-80.
    PubMed     Text format     Abstract available
    
    
13. CORCORAN M, Mereckiene J, Cotter S, Murchan S, et al
    Invasive Streptococcus pneumoniae Infections and Vaccine Failures in Children in Ireland From the Postvaccine Era From 2007 to 2018.
    Pediatr Infect Dis J. 2019 Dec 2. doi: 10.1097/INF.0000000000002549.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Med

14. LEE EC, Azman AS, Kaminsky J, Moore SM, et al
    The projected impact of geographic targeting of oral cholera vaccination in sub-Saharan Africa: A modeling study.
    PLoS Med. 2019;16:e1003003.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

15. ABDO Z, LeCureux J, LaVoy A, Eklund B, et al
    Impact of oral probiotic Lactobacillus acidophilus vaccine strains on the immune response and gut microbiome of mice.
    PLoS One. 2019;14:e0225842.
    PubMed     Text format     Abstract available
    
    
16. 
    Correction: An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway.
    PLoS One. 2019;14:e0226706.
    PubMed     Text format     Abstract available
    
    
17. HEINSON AI, Ewing RM, Holloway JW, Woelk CH, et al
    An evaluation of different classification algorithms for protein sequence-based reverse vaccinology prediction.
    PLoS One. 2019;14:e0226256.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

18. YU KM, Park SJ, Yu MA, Kim YI, et al
    Cross-genotype protection of live-attenuated vaccine candidate for severe fever with thrombocytopenia syndrome virus in a ferret model.
    Proc Natl Acad Sci U S A. 2019 Dec 9. pii: 1914704116.
    PubMed     Text format     Abstract available
    
    

    
    Vaccine

19. SUN X, Wagner AL, Ji J, Huang Z, et al
    A conjoint analysis of stated vaccine preferences in Shanghai, China.
    Vaccine. 2019 Dec 7. pii: S0264-410X(19)31616.
    PubMed     Text format     Abstract available
    
    
20. LI Y, Zhu P, Wu M, Zhang Y, et al
    Immunogenicity and safety of human papillomavirus vaccine coadministered with other vaccines in individuals aged 9-25years: A systematic review and meta-analysis.
    Vaccine. 2019 Dec 9. pii: S0264-410X(19)31481.
    PubMed     Text format     Abstract available
    
    
21. KURATA T, Kanbayashi D, Egawa K, Kinoshita M, et al
    A measles outbreak from an index case with immunologically confirmed secondary vaccine failure.
    Vaccine. 2019 Dec 9. pii: S0264-410X(19)31629.
    PubMed     Text format     Abstract available
    
    
22. ECARNOT F, Pedone C, Cesari M, Maggi S, et al
    Knowledge about vaccines and vaccination in older people: Results of a national survey by the Italian Society for Gerontology & Geriatrics.
    Vaccine. 2019 Dec 7. pii: S0264-410X(19)31619.
    PubMed     Text format     Abstract available
    
    
23. WILSON R, Zaytseva A, Bocquier A, Nokri A, et al
    Vaccine hesitancy and self-vaccination behaviors among nurses in southeastern France.
    Vaccine. 2019 Dec 3. pii: S0264-410X(19)31541.
    PubMed     Text format     Abstract available
    
    
24. KO MK, Jo HE, Choi JH, You SH, et al
    Improved foot-and-mouth disease vaccine with O PanAsia-2 strain protect pigs against O/Jincheon/SKR/2014 originated from South Korea.
    Vaccine. 2019 Dec 3. pii: S0264-410X(19)31554.
    PubMed     Text format     Abstract available
    
    
25. PAN SC, Hsu WT, Lee WS, Wang NC, et al
    A double-blind, randomized controlled trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with the adjuvant LTh(alphaK): A phase II study.
    Vaccine. 2019 Dec 4. pii: S0264-410X(19)31589.
    PubMed     Text format     Abstract available
    
    
26. DUONG TN, Thiem VD, Anh DD, Cuong NP, et al
    A Phase 2/3 double blinded, randomized, placebo-controlled study in healthy adult participants in Vietnam to examine the safety and immunogenicity of an inactivated whole virion, alum adjuvanted, A(H5N1) influenza vaccine (IVACFLU-A/H5N1).
    Vaccine. 2019 Dec 4. pii: S0264-410X(19)31601.
    PubMed     Text format     Abstract available
    
    
27. MACK I, Erlanger TE, Lang P, Sinniger P, et al
    Dose-dependent effectiveness of acellular pertussis vaccine in infants: A population-based case-control study.
    Vaccine. 2019 Dec 5. pii: S0264-410X(19)31623.
    PubMed     Text format     Abstract available
    
    
28. YAN X, Zhou M, Yu S, Jin Z, et al
    An overview of biodegradable nanomaterials and applications in vaccines.
    Vaccine. 2019 Dec 5. pii: S0264-410X(19)31556.
    PubMed     Text format     Abstract available
    
    
29. ENTICOTT G, Maye D, Naylor R, Brunton L, et al
    An assessment of risk compensation and spillover behavioural adaptions associated with the use of vaccines in animal disease management.
    Vaccine. 2019 Dec 5. pii: S0264-410X(19)31562.
    PubMed     Text format     Abstract available
    
    
30. GAO Z, Robinson K, Skowronski DM, De Serres G, et al
    Quantification of the total neuraminidase content of recent commercially-available influenza vaccines: Introducing a neuraminidase titration reagent.
    Vaccine. 2019 Dec 6. pii: S0264-410X(19)31570.
    PubMed     Text format     Abstract available
    
    
31. TAVARES-DA-SILVA F, Miranda M, Dessart C, Herve C, et al
    Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine.
    Vaccine. 2019 Dec 6. pii: S0264-410X(19)31600.
    PubMed     Text format     Abstract available
    
    
32. SAUL A, Podda A, Rappuoli R
    The use and abuse of a 4-fold increase in antibody response to assess immunogenicity in early stage vaccine clinical trials.
    Vaccine. 2019 Dec 7. pii: S0264-410X(19)31621.
    PubMed     Text format    
    
    
33. LACONI A, Weerts EAWS, Bloodgood JCG, Deniz Marrero JP, et al
    Attenuated live infectious bronchitis virus QX vaccine disseminates slowly to target organs distant from the site of inoculation.
    Vaccine. 2019 Dec 7. pii: S0264-410X(19)31618.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: